The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nalefski, E. A.
Right arrow Articles by Rao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nalefski, E. A.
Right arrow Articles by Rao, A.

The Journal of Immunology, Vol 150, Issue 9 3806-3816, Copyright © 1993 by American Association of Immunologists


ARTICLES

Nature of the ligand recognized by a hapten- and carrier-specific, MHC- restricted T cell receptor

EA Nalefski and A Rao
Program in Cell and Development Biology, Harvard Medical School, Boston, MA 02115.

The hapten- and carrier-specific T lymphocyte clone D5 and a T hybridoma (D5h) derived from D5 cells recognize several different protein Ag conjugated with p-azobenzenearsonate (arsonate) presented by the class II MHC protein I-Ad. We show here that the ligand recognized by the D5 TCR is a complex of a haptenated peptide bound to I-Ad. We have identified a peptide fragment generated by enzymatic cleavage of arsonate-conjugated OVA (Ars-OVA), which stimulates D5 cells when presented by I-Ad-bearing APC. A synthetic peptide corresponding to this fragment, OVA(36-50), forms a ligand for D5h cells when it is conjugated with arsonate and presented by cells bearing I-Ad. Paraformaldehyde-fixed, I-Ad-bearing cells present Ars-OVA(36-50), or the longer stimulatory peptide Ars-OVA(33-49), to D5h cells, demonstrating that haptenated synthetic peptides can substitute for naturally processed antigenic peptides. The peptide Ars-OVA(33-49) binds to the major peptide-binding site of I-Ad because it competitively inhibited presentation of the peptide OVA(323-339), previously demonstrated to bind to I-Ad directly in vitro, to the OVA/I- Ad-specific T cell hybridoma 3DO-54.8. The unconjugated OVA(33-49) peptide failed to inhibit the presentation of OVA(323-339), demonstrating that the hapten facilities binding of the peptide to I- Ad. Conversely, the peptide OVA(323-339) competitively inhibited the presentation of Ars-OVA(33-49) to D5h cells, indicating that the two peptides Ars-OVA(33-49) and OVA(323-339) bind to overlapping sites on I- Ad. Amino acid substitutions introduced into the beta 1 domain of I-Ad that affected recognition of OVA(323-339) by 3DO-54.8 cells also affected recognition of Ars-OVA(33-50) by D5h cells, demonstrating that similar regions on I-Ad are required for TCR recognition of conventional as well as haptenated peptides. These results represent the first demonstration that the ligand recognized by a hapten- and carrier-specific T cell clone restricted to an MHC class II protein is a haptenated peptide Ag bound to the MHC molecule.


This article has been cited by other articles:


Home page
Int ImmunolHome page
T. Shimizu, Y. Osaka, C. Banri-Koike, M. Yoshida, K. Endo, K. Furukawa, M. Oda, A. Murakami, S. Ogawa, R. Abe, et al.
T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies
Int. Immunol., October 1, 2007; 19(10): 1157 - 1164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Stockl, O. Majdic, G. Fischer, D. Maurer, and W. Knapp
Monomorphic Molecules Function as Additional Recognition Structures on Haptenated Target Cells for HLA-A1-Restricted, Hapten-Specific CTL
J. Immunol., September 1, 2001; 167(5): 2724 - 2733.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Vollmer, H. U. Weltzien, K. Gamerdinger, S. Lang, Y. Choleva, and C. Moulon
Antigen contacts by Ni-reactive TCR: typical {alpha}{beta} chain cooperation versus {alpha} chain-dominated specificity
Int. Immunol., December 1, 2000; 12(12): 1723 - 1731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Kessler, O. Michielin, C. L. Blanchard, I. Apostolou, C. Delarbre, G. Gachelin, C. Gregoire, B. Malissen, J.-C. Cerottini, F. Wurm, et al.
T Cell Recognition of Hapten. ANATOMY OF T CELL RECEPTOR BINDING OF A H-2Kd-ASSOCIATED PHOTOREACTIVE PEPTIDE DERIVATIVE
J. Biol. Chem., February 5, 1999; 274(6): 3622 - 3631.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Preckel, R. Grimm, S. Martin, and H. U. Weltzien
Altered Hapten Ligands Antagonize Trinitrophenyl-specific Cytotoxic T Cells and Block Internalization of Hapten-specific Receptors
J. Exp. Med., May 19, 1997; 185(10): 1803 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Anjuere, D. Kuznetsov, P. Romero, J.-C. Cerottini, C. V. Jongeneel, and I. F. Luescher
Differential Roles of T Cell Receptor alpha and beta Chains in Ligand Binding Among H-2Kd-restricted Cytolytic T Lymphocyte Clones Specific for a Photoreactive Plasmodium berghei Circumsporozoite Peptide Derivative
J. Biol. Chem., March 28, 1997; 272(13): 8505 - 8514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Nalefski, K. T. Y. Shaw, and A. Rao
An Ion Pair in Class II Major Histocompatibility Complex Heterodimers Critical for Surface Expression and Peptide Presentation
J. Biol. Chem., September 22, 1995; 270(38): 22351 - 22360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.